Nicolas Parmentier

2.9k total citations · 1 hit paper
10 papers, 2.2k citations indexed

About

Nicolas Parmentier is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Nicolas Parmentier has authored 10 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Cancer Research. Recurrent topics in Nicolas Parmentier's work include Ubiquitin and proteasome pathways (4 papers), RNA modifications and cancer (3 papers) and Immunotherapy and Immune Responses (3 papers). Nicolas Parmentier is often cited by papers focused on Ubiquitin and proteasome pathways (4 papers), RNA modifications and cancer (3 papers) and Immunotherapy and Immune Responses (3 papers). Nicolas Parmentier collaborates with scholars based in Belgium, France and Qatar. Nicolas Parmentier's co-authors include Benoı̂t J. Van den Eynde, Didier Colau, Vincent Stroobant, Ivan Théate, Catherine Uyttenhove, Thierry Boon, Luc Pilotte, Jacques Chapiro, Benoît Guillaume and Marie‐Pierre Bousquet and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Nicolas Parmentier

10 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

2003 1.8k citations Catherine Uyttenhove, Luc Pilotte et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicolas Parmentier Belgium	7	1.0k	845	793	785	285	10	2.2k
Preston S. Donover United States	11	354 0.4×	559 0.7×	498 0.6×	284 0.4×	174 0.6×	18	1.2k
Katharina Ochs Germany	14	379 0.4×	455 0.5×	361 0.5×	298 0.4×	167 0.6×	18	1.2k
Michael Hansbury United States	12	176 0.2×	302 0.4×	396 0.5×	221 0.3×	88 0.3×	18	860
Nicholas B. Jennings United States	27	238 0.2×	54 0.1×	1.3k 1.7×	718 0.9×	150 0.5×	45	2.5k
Mark Fidock United Kingdom	20	358 0.4×	52 0.1×	807 1.0×	121 0.2×	40 0.1×	32	1.6k
Han Yao China	16	502 0.5×	25 0.0×	653 0.8×	742 0.9×	39 0.1×	36	1.6k
Csilla Fazakas Hungary	18	182 0.2×	53 0.1×	526 0.7×	371 0.5×	25 0.1×	40	1.4k
Shari L. Sutor United States	23	555 0.6×	47 0.1×	989 1.2×	683 0.9×	27 0.1×	33	1.8k
Donna L. Herber United States	9	1.3k 1.3×	103 0.1×	565 0.7×	566 0.7×	6 0.0×	13	2.1k

Countries citing papers authored by Nicolas Parmentier

Since Specialization

Citations

This map shows the geographic impact of Nicolas Parmentier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Parmentier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Parmentier more than expected).

Fields of papers citing papers by Nicolas Parmentier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Parmentier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Parmentier. The network helps show where Nicolas Parmentier may publish in the future.

Co-authorship network of co-authors of Nicolas Parmentier

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Parmentier. A scholar is included among the top collaborators of Nicolas Parmentier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Parmentier. Nicolas Parmentier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Dutheuil, Guillaume, Killian Oukoloff, François Lenoir, et al.. (2025). Discovery, Optimization, and Preclinical Pharmacology of EP652, a METTL3 Inhibitor with Efficacy in Liquid and Solid Tumor Models. Journal of Medicinal Chemistry. 68(3). 2981–3003. 7 indexed citations

2.

Fraser, Graeme, et al.. (2023). EP102: Pharmacological Inhibition of METTL3 Elicits Tumor Growth Inhibition In Vivo and Demonstrates Synergy with Venetoclax in Various AML Models. Blood. 142(Supplement 1). 2263–2263. 4 indexed citations

3.

Fraser, Graeme, et al.. (2023). Abstract 6282: EP102: Pharmacological inhibition of METTL3 arrests tumor progression and prolongs survival in CDX and PDX models of AML. Cancer Research. 83(7_Supplement). 6282–6282. 3 indexed citations

4.

Hakanen, Janne, Nicolas Parmentier, Mohamed Aittaleb, et al.. (2021). The Celsr3-Kif2a axis directs neuronal migration in the postnatal brain. Progress in Neurobiology. 208. 102177–102177. 5 indexed citations

5.

Parmentier, Nicolas, et al.. (2019). Dystroglycan is a scaffold for extracellular axon guidance decisions. eLife. 8. 32 indexed citations

6.

Guillaume, Benoît, Vincent Stroobant, Marie‐Pierre Bousquet, et al.. (2012). Analysis of the Processing of Seven Human Tumor Antigens by Intermediate Proteasomes. The Journal of Immunology. 189(7). 3538–3547. 67 indexed citations

7.

Parmentier, Nicolas, Vincent Stroobant, Didier Colau, et al.. (2010). Production of an antigenic peptide by insulin-degrading enzyme. Nature Immunology. 11(5). 449–454. 53 indexed citations

8.

Guillaume, Benoît, Jacques Chapiro, Vincent Stroobant, et al.. (2010). Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I molecules. Proceedings of the National Academy of Sciences. 107(43). 18599–18604. 180 indexed citations

9.

Geiss‐Friedlander, Ruth, Nicolas Parmentier, Ulrike Möller, et al.. (2009). The Cytoplasmic Peptidase DPP9 Is Rate-limiting for Degradation of Proline-containing Peptides. Journal of Biological Chemistry. 284(40). 27211–27219. 85 indexed citations

10.

Uyttenhove, Catherine, Luc Pilotte, Ivan Théate, et al.. (2003). Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nature Medicine. 9(10). 1269–1274. 1807 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact